XML 27 R13.htm IDEA: XBRL DOCUMENT
v3.21.2

Fair Value Measurements | 6 Months Ended
--- | ---
Sep. 30, 2021
Fair Value Disclosures [Abstract] |
Fair Value Measurements | Fair Value Measurements The Company measures certain liabilities at fair value on a recurring basis. The following tables provide details regarding the classification of these liabilities within the fair value hierarchy as of the dates presented:
| As of September 30, 2021
| Level I |  | Level II |  | Level III |  | Total
Liabilities |  |  |  |  |  |  |
Contingent consideration obligation | $ | — |  |  | $ | — |  |  | $ | 18,851 |  |  | $ | 18,851 |
Total liabilities | $ | — |  |  | $ | — |  |  | $ | 18,851 |  |  | $ | 18,851 |
| As of March 31, 2021
| Level I |  | Level II |  | Level III |  | Total
Liabilities |  |  |  |  |  |  |
Contingent consideration obligation | $ | — |  |  | $ | — |  |  | $ | 1,541 |  |  | $ | 1,541 |
Total liabilities | $ | — |  |  | $ | — |  |  | $ | 1,541 |  |  | $ | 1,541 |
For the liabilities presented in the tables above, there were no changes in fair value hierarchy levels during the three and six months ended September 30, 2021 and 2020. The changes in the fair value of Level III financial instruments are set forth below:
| Three Months Ended September 30, |  | Six Months Ended September 30,
| 2021 |  | 2020 |  | 2021 |  | 2020
Contingent Consideration Liability |  |  |  |  |  |  |
Balance, beginning of period: | $ | 1,306 |  |  | $ | 745 |  |  | $ | 1,541 |  |  | $ | 1,035 |
Additions | 17,769 |  |  | — |  |  | 17,769 |  |  | — |
(Gain) loss on change in fair value | — |  |  | — |  |  | — |  |  | — |
Settlements | (224) |  |  | (271) |  |  | (459) |  |  | (561) |
Balance, end of period: | $ | 18,851 |  |  | $ | 474 |  |  | $ | 18,851 |  |  | $ | 474 |
Changes in unrealized (gains) losses included in earnings related to financial liabilities still held at the reporting date | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
In connection with the Greenspring acquisition, the Company recorded a contingent consideration liability of $17.8 million during the three months ended September 30, 2021. See note 14 for more information. The fair value of the contingent consideration liability is based on a discounted cash flow analysis using a probability-weighted average estimate of certain performance targets, including revenue levels. The assumptions used in the analysis are inherently subjective; therefore, the ultimate amount of the contingent consideration liability may differ materially from the current estimate. The significant unobservable inputs required to value the contingent consideration liabilities primarily relate to the discount rates applied to the expected future revenue and payment obligations, which ranged from 3% to 10% as of September 30, 2021. The contingent consideration liabilities are included in accounts payable, accrued expenses and other liabilities in the condensed consolidated balance sheets. Changes in the fair value of the liability are included in general, administrative and other expenses in the condensed consolidated statements of income.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration